|
1
|
Baniak N, Senger JL, Ahmed S, Kanthan SC
and Kanthan R: Gastric biomarkers: A global review. World J Surg
Oncol. 14:2122016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Corso S and Giordano S: How can gastric
cancer molecular profiling guide future therapies? Trends Mol Med.
22:534–544. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kumar R, Gururaj AE and Barnes CJ:
p21-activated kinases in cancer. Nat Rev Cancer. 6:459–471. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jaffer ZM and Chernoff J: p21-activated
kinases: Three more join the Pak. Int J Biochem Cell Biol.
34:713–717. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Abo A, Qu J, Cammarano MS, Dan C, Fritsch
A, Baud V, Belisle B and Minden A: PAK4, a novel effector for
Cdc42Hs, is implicated in the reorganization of the actin
cytoskeleton and in the formation of filopodia. EMBO J.
17:6527–6540. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Callow MG, Clairvoyant F, Zhu S, Schryver
B, Whyte DB, Bischoff JR, Jallal B and Smeal T: Requirement for
PAK4 in the anchorage-independent growth of human cancer cell
lines. J Biol Chem. 277:550–558. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wells CM, Whale AD, Parsons M, Masters JR
and Jones GE: PAK4: A pluripotent kinase that regulates prostate
cancer cell adhesion. J Cell Sci. 123:1663–1673. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nekrasova T and Minden A: PAK4 is required
for regulation of the cell-cycle regulatory protein p21, and for
control of cell-cycle progression. J Cell Biochem. 112:1795–1806.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li X and Minden A: PAK4 functions in tumor
necrosis factor (TNF) alpha-induced survival pathways by
facilitating TRADD binding to the TNF receptor. J Biol Chem.
280:41192–41200. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ahn HK, Jang J, Lee J, Hoon Se P, Park JO,
Park YS, Lim HY, Kim KM and Kang WK: P21-activated kinase 4
overexpression in metastatic gastric cancer patients. Transl Oncol.
4:345–349. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li X, Ke Q, Li Y, Liu F, Zhu G and Li F:
DGCR6L, a novel PAK4 interaction protein, regulates PAK4-mediated
migration of human gastric cancer cell via LIMK1. Int J Biochem
Cell Biol. 42:70–79. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guo Q, Su N, Zhang J, Li X, Miao Z, Wang
G, Cheng M, Xu H, Cao L and Li F: PAK4 kinase-mediated SCG10
phosphorylation involved in gastric cancer metastasis. Oncogene.
33:3277–3287. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Negrutskii BS and El'skaya AV: Eukaryotic
translation elongation factor 1 alpha: Structure, expression,
functions, and possible role in aminoacyl-tRNA channeling. Prog
Nucleic Acid Res Mol Biol. 60:47–78. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Browne GJ and Proud CG: Regulation of
peptide-chain elongation in mammalian cells. Eur J Biochem.
269:5360–5368. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Knudsen SM, Frydenberg J, Clark BF and
Leffers H: Tissue-dependent variation in the expression of
elongation factor-1 alpha isoforms: Isolation and characterisation
of a cDNA encoding a novel variant of human elongation-factor 1
alpha. Eur J Biochem. 215:549–554. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Abbas W, Kumar A and Herbein G: The eEF1A
proteins: At the crossroads of oncogenesis, apoptosis, and viral
infections. Front Oncol. 5:752015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shiina N, Gotoh Y, Kubomura N, Iwamatsu A
and Nishida E: Microtubule severing by elongation factor 1 alpha.
Science. 266:282–285. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pittman YR, Kandl K, Lewis M, Valente L
and Kinzy TG: Coordination of eukaryotic translation elongation
factor 1A (eEF1A) function in actin organization and translation
elongation by the guanine nucleotide exchange factor eEF1Balpha. J
Biol Chem. 284:4739–4747. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Khacho M, Mekhail K, Pilon-Larose K, Pause
A, Côté J and Lee S: eEF1A is a novel component of the mammalian
nuclear protein export machinery. Mol Biol Cell. 19:5296–5308.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chuang SM, Chen L, Lambertson D, Anand M,
Kinzy TG and Madura K: Proteasome-mediated degradation of
cotranslationally damaged proteins involves translation elongation
factor 1A. Mol Cell Biol. 25:403–413. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li D, Wei T, Abbott CM and Harrich D: The
unexpected roles of eukaryotic translation elongation factors in
RNA virus replication and pathogenesis. Microbiol Mol Biol Rev.
77:253–266. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee MH and Surh YJ: eEF1A2 as a putative
oncogene. Ann NY Acad Sci. 1171:87–93. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tomlinson VA, Newbery HJ, Wray NR, Jackson
J, Larionov A, Miller WR, Dixon JM and Abbott CM: Translation
elongation factor eEF1A2 is a potential oncoprotein that is
overexpressed in two-thirds of breast tumours. BMC Cancer.
5:1132005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Anand N, Murthy S, Amann G, Wernick M,
Porter LA, Cukier IH, Collins C, Gray JW, Diebold J, Demetrick DJ,
et al: Protein elongation factor EEF1A2 is a putative oncogene in
ovarian cancer. Nat Genet. 31:301–305. 2002.PubMed/NCBI
|
|
26
|
Li R, Wang H, Bekele BN, Yin Z, Caraway
NP, Katz RL, Stass SA and Jiang F: Identification of putative
oncogenes in lung adenocarcinoma by a comprehensive functional
genomic approach. Oncogene. 25:2628–2635. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang S, Lu M, Chen Y, Meng D, Sun R, Yun
D, Zhao Z, Lu D and Li Y: Overexpression of eukaryotic elongation
factor 1 alpha-2 is associated with poorer prognosis in patients
with gastric cancer. J Cancer Res Clin Oncol. 141:1265–1275. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gross SR and Kinzy TG: Translation
elongation factor 1A is essential for regulation of the actin
cytoskeleton and cell morphology. Nat Struct Mol Biol. 12:772–778.
2005. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shao YG, Ning K and Li F: Group II
p21-activated kinases as therapeutic targets in gastrointestinal
cancer. World J Gastroenterol. 22:1224–1235. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kobayashi K, Inokuchi M, Takagi Y, Otsuki
S, Fujimori Y, Sato Y, Yanaka Y, Higuchi K, Aburatani T, Tomii C,
et al: Prognostic significance of PAK4 expression in gastric
cancer. J Clin Pathol. 69:580–585. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li D, Zhang Y, Li Z, Wang X, Qu X and Liu
Y: Activated Pak4 expression correlates with poor prognosis in
human gastric cancer patients. Tumour Biol. 36:9431–9436. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ahmed T, Shea K, Masters JR, Jones GE and
Wells CM: A PAK4-LIMK1 pathway drives prostate cancer cell
migration downstream of HGF. Cell Signal. 20:1320–1328. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Siu MK, Chan HY, Kong DS, Wong ES, Wong
OG, Ngan HY, Tam KF, Zhang H, Li Z, Chan QK, et al: p21-activated
kinase 4 regulates ovarian cancer cell proliferation, migration,
and invasion and contributes to poor prognosis in patients. Proc
Natl Acad Sci USA. 107:18622–18627. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Amiri A, Noei F, Jeganathan S, Kulkarni G,
Pinke DE and Lee JM: eEF1A2 activates Akt and stimulates
Akt-dependent actin remodeling, invasion and migration. Oncogene.
26:3027–3040. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jeganathan S, Morrow A, Amiri A and Lee
JM: Eukaryotic elongation factor 1A2 cooperates with
phosphatidylinositol-4 kinase III beta to stimulate production of
filopodia through increased phosphatidylinositol-4,5 bisphosphate
generation. Mol Cell Biol. 28:4549–4561. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li Z, Qi CF, Shin DM, Zingone A, Newbery
HJ, Kovalchuk AL, Abbott CM and Morse HC III: Eef1a2 promotes cell
growth, inhibits apoptosis and activates JAK/STAT and AKT signaling
in mouse plasmacytomas. PLoS One. 5:e107552010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhuang T, Zhu J, Li Z, Lorent J, Zhao C,
Dahlman-Wright K and Strömblad S: p21-activated kinase group II
small compound inhibitor GNE-2861 perturbs estrogen receptor alpha
signaling and restores tamoxifen-sensitivity in breast cancer
cells. Oncotarget. 6:43853–43868. 2015.PubMed/NCBI
|
|
38
|
Xu HT, Lai WL, Liu HF, Wong LL, Ng IO and
Ching YP: PAK4 Phosphorylates p53 at Serine 215 to Promote Liver
Cancer Metastasis. Cancer Res. 76:5732–5742. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gnesutta N, Qu J and Minden A: The
serine/threonine kinase PAK4 prevents caspase activation and
protects cells from apoptosis. J Biol Chem. 276:14414–14419.
2001.PubMed/NCBI
|
|
40
|
Gnesutta N and Minden A: Death
receptor-induced activation of initiator caspase 8 is antagonized
by serine/threonine kinase PAK4. Mol Cell Biol. 23:7838–7848. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang C, Li Y, Zhang H, Liu F, Cheng Z,
Wang D, Wang G, Xu H, Zhao Y, Cao L, et al: Oncogenic PAK4
regulates Smad2/3 axis involving gastric tumorigenesis. Oncogene.
33:3473–3484. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Borradaile NM, Buhman KK, Listenberger LL,
Magee CJ, Morimoto ET, Ory DS and Schaffer JE: A critical role for
eukaryotic elongation factor 1A-1 in lipotoxic cell death. Mol Biol
Cell. 17:770–778. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Bunai F, Ando K, Ueno H and Numata O:
Tetrahymena eukaryotic translation elongation factor 1A (eEF1A)
bundles filamentous actin through dimer formation. J Biochem.
140:393–399. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Dahl LD, Corydon TJ, Ränkel L, Nielsen KM,
Füchtbauer EM and Knudsen CR: An eEF1A1 truncation encoded by PTI-1
exerts its oncogenic effect inside the nucleus. Cancer Cell Int.
14:172014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhao Q, He Y, Wang XL, Zhang YX and Wu YM:
Differentially expressed proteins among normal cervix, cervical
intraepithelial neoplasia and cervical squamous cell carcinoma.
Clin Transl Oncol. 17:620–631. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhan C, Zhang Y, Ma J, Wang L, Jiang W,
Shi Y and Wang Q: Identification of reference genes for qRT-PCR in
human lung squamous-cell carcinoma by RNA-Seq. Acta Biochim Biophys
Sin (Shanghai). 46:330–337. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Maltseva DV, Khaustova NA, Fedotov NN,
Matveeva EO, Lebedev AE, Shkurnikov MU, Galatenko VV, Schumacher U
and Tonevitsky AG: High-throughput identification of reference
genes for research and clinical RT-qPCR analysis of breast cancer
samples. J Clin Bioinforma. 3:132013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Edmonds BT, Wyckoff J, Yeung YG, Wang Y,
Stanley ER, Jones J, Segall J and Condeelis J: Elongation factor-1
alpha is an overexpressed actin binding protein in metastatic rat
mammary adenocarcinoma. J Cell Sci. 109:2705–2714. 1996.PubMed/NCBI
|
